Management of CNS germinoma
- PMID: 26118663
- PMCID: PMC6088312
- DOI: 10.2217/cns.15.13
Management of CNS germinoma
Abstract
The following is a general overview of the management of CNS germinomas. Over the last 35 years, CNS germinomas have become one of the pediatric brain tumors with the best outcomes with a greater than 85% overall survival over 5 years. This is in part due to the fact that germinomas are very responsive to chemotherapy and radiation. Some of the major challenges going forward will be to find ways to minimize the adverse effects of our treatments particularly with regard to radiation and to improve the quality of life of patients who develop neurologic, neurocognitive and/or endocrine deficiencies.
Keywords: BHCG; CNS; brain tumor; chemotherapy; germ cell tumor; germinoma; management; pediatric; pure germinoma; radiation.
Conflict of interest statement
Figures
References
-
- Horowitz MB, Hall WA. Central nervous system germinomas: a review. Arch. Neurol. 1991;48(6):652–657. - PubMed
-
- Echevarria ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist. 2008;13(6):690–699. - PubMed
-
- Thakkar JP, Chew L, Villano JL. Primary CNS germ cell tumors: current epidemiology and update on treatment. Med. Oncol. 2013;30(2):496. - PubMed
-
- Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg. 1985;63(2):155–167. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases